| Monoclonal antibody therapy for COVID-19 in solid organ transplant recipients ZA Yetmar, E Beam, JC O’Horo, R Ganesh, DM Bierle, L Brumble, ... Open forum infectious diseases 8 (6), ofab255, 2021 | 67 | 2021 |
| Outcomes of COVID-19 with the Mayo Clinic model of care and research JC O’Horo, JR Cerhan, EJ Cahn, PR Bauer, Z Temesgen, J Ebbert, ... Mayo Clinic Proceedings 96 (3), 601-618, 2021 | 32 | 2021 |
| Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild‐to‐moderate coronavirus disease 2019 during the Omicron epoch ZA Yetmar, E Beam, JC O'Horo, MT Seville, L Brumble, R Ganesh, ... Transplant Infectious Disease 24 (4), e13901, 2022 | 30 | 2022 |
| The Characteristics of Capnocytophaga Infection: 10 Years of Experience S Chesdachai, DBG Tai, ZA Yetmar, A Misra, N Ough, O Abu Saleh Open Forum Infectious Diseases 8 (7), ofab175, 2021 | 30 | 2021 |
| Inpatient care of patients with COVID-19: a guide for hospitalists ZA Yetmar, M Issa, S Munawar, MC Burton, V Pureza, MR Sohail, ... The American journal of medicine 133 (9), 1019-1024, 2020 | 28 | 2020 |
| Breakthrough COVID‐19 after SARS‐CoV‐2 vaccination in solid organ transplant recipients: an analysis of symptomatic cases and monoclonal antibody therapy ZA Yetmar, E Bhaimia, DM Bierle, R Ganesh, RR Razonable Transplant Infectious Disease 24 (2), e13779, 2022 | 21 | 2022 |
| Cryptococcus Species Other Than Cryptococcus neoformans and Cryptococcus gattii: Are They Clinically Significant? EJ Cano, ZA Yetmar, RR Razonable Open Forum Infectious Diseases 7 (12), ofaa527, 2020 | 15 | 2020 |
| Outcomes of nocardiosis and treatment of disseminated infection in solid organ transplant recipients ZA Yetmar, DW Challener, MT Seville, W Bosch, E Beam Transplantation 107 (3), 782-791, 2023 | 13 | 2023 |
| Prior statin use and risk of mortality and severe disease from coronavirus disease 2019: a systematic review and meta-analysis ZA Yetmar, S Chesdachai, T Kashour, M Riaz, DJ Gerberi, AD Badley, ... Open Forum Infectious Diseases 8 (7), ofab284, 2021 | 13 | 2021 |
| Association between chronic statin use and 30-day mortality in hospitalized patients with COVID-19 ZA Yetmar, DW Challener, IM Tleyjeh, MR Sohail, JR Cerhan, AD Badley, ... Mayo Clinic Proceedings: Innovations, Quality & Outcomes 5 (2), 442-446, 2021 | 11 | 2021 |
| Risk factors and outcomes of nocardiosis in hematopoietic stem cell transplantation recipients ZA Yetmar, MJ Thoendel, W Bosch, MT Seville, WJ Hogan, E Beam Transplantation and Cellular Therapy 29 (3), 206. e1-206. e7, 2023 | 10 | 2023 |
| Outcomes of B-cell-depleted patients with coronavirus disease 2019 treated with antispike monoclonal antibodies ZA Yetmar, RB Khodadadi, MT Seville, L Brumble, JC O’Horo, R Ganesh, ... Open forum infectious diseases 9 (7), ofac204, 2022 | 10 | 2022 |
| Recurrent nocardiosis in solid organ transplant recipients: an evaluation of secondary prophylaxis ZA Yetmar, JW Wilson, E Beam Transplant Infectious Disease 23 (6), e13753, 2021 | 10 | 2021 |
| Antistaphylococcal Penicillin vs Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Spinal Epidural Abscesses C Corsini Campioli, JR Go, O Abu Saleh, D Challener, Z Yetmar, ... Open Forum Infectious Diseases 8 (3), ofab071, 2021 | 10 | 2021 |
| Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia ZA Yetmar, RB Khodadadi, JR Go, S Chesdachai, OM Abu Saleh European Journal of Clinical Microbiology & Infectious Diseases 42 (4), 423-430, 2023 | 9 | 2023 |
| Contemporary experience of Abiotrophia, Granulicatella and Gemella bacteremia S Chesdachai, ZA Yetmar, H Tabaja, IY Comba, JR Go, DW Challener, ... Journal of Infection 84 (4), 511-517, 2022 | 9 | 2022 |
| Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta-analysis ZA Yetmar, S Razi, T Nayfeh, DJ Gerberi, M Mahmood, OMA Saleh International Journal of Antimicrobial Agents 59 (1), 106486, 2022 | 8 | 2022 |
| Successful liver transplantation from a SARS-CoV-2 positive donor to a positive recipient: potential role of monoclonal antibodies ZA Yetmar, N Ranganath, RC Huebert, CB Rosen, RR Razonable, ... Transplantation 106 (3), e181-e182, 2022 | 7 | 2022 |
| Mortality after nocardiosis: risk factors and evaluation of disseminated infection ZA Yetmar, RB Khodadadi, S Chesdachai, JW McHugh, DW Challener, ... Open Forum Infectious Diseases 10 (8), ofad409, 2023 | 6 | 2023 |
| Risk factors and outcomes of non-tuberculous mycobacteria infection in lung transplant recipients: A systematic review and meta-analysis PK Marty, ZA Yetmar, DJ Gerberi, P Escalante, KM Pennington, ... The Journal of Heart and Lung Transplantation 42 (2), 264-274, 2023 | 6 | 2023 |
Elena BeamVerified email at mayo.edu
